Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $117.1700 (2.47%) ($113.3000 - $117.7300) on Wed. Jul. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.08% (three month average) | RSI | 55 | Latest Price | $117.1700(2.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1% a day on average for past five trading days. | Weekly Trend | LGND advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.04% in a week (0% probabilities). VIXM(-33%) VXX(-21%) TLT(-15%) IFRA(-8%) UUP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.04% (StdDev 2.08%) | Hourly BBV | 0 () | Intraday Trend | 1.7% | | | |
|
5 Day Moving Average | $114.91(1.97%) | 10 Day Moving Average | $113.06(3.64%) | 20 Day Moving Average | $112.42(4.23%) | To recent high | -9.4% | To recent low | 9.1% | Market Cap | $1.883b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |